Eric M Dube
Director, CHIEF EXECUTIVE OFFICER · 7 filings · Latest: Sep 15, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Dube Eric M | — | Feb 20, 2026 | Proposed Sale | $30.10 | 60,000 | $1.8M | — | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Feb 3, 2026 | Sale | $32.28 | 100,087 | $3.2M | 432,886 | |
TVTX | Dube Eric M | — | Feb 3, 2026 | Proposed Sale | $32.87 | 100,087 | $3.3M | — | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Jan 27, 2026 | Sale | $30.10 | 51,865 | $1.6M | 419,173 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Jan 27, 2026 | Option Exercise | $15.46 | 51,865 | $801.8K | 471,038 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Jan 23, 2026 | Sale | $30.01 | 8,135 | $244.2K | 419,173 | |
TVTX | Eric M Dube | Director, CHIEF EXECUTIVE OFFICER | Jan 23, 2026 | Option Exercise | $15.46 | 8,135 | $125.8K | 427,308 | |
TVTX | Dube Eric M | — | Jan 27, 2026 | Proposed Sale | $30.10 | 51,865 | $1.6M | — | |
TVTX | Dube Eric M | — | Jan 23, 2026 | Proposed Sale | $30.01 | 8,135 | $244.2K | — | |
TVTX | Dube Eric M | — | Oct 29, 2025 | Proposed Sale | $30.12 | 27,128 | $817.0K | — | |
TVTX | Dube Eric M | — | Oct 28, 2025 | Proposed Sale | $30.38 | 92,872 | $2.8M | — | |
TVTX | Dube Eric M | — | May 5, 2025 | Proposed Sale | $21.05 | 18,924 | $398.4K | — | |
TVTX | Dube Eric M | — | Feb 11, 2025 | Proposed Sale | $24.04 | 11,375 | $273.5K | — | |
TVTX | Dube Eric M | — | Feb 3, 2025 | Proposed Sale | $19.78 | 50,691 | $1.0M | — | |
TVTX | Dube Eric M | — | Jan 22, 2025 | Proposed Sale | $19.46 | 10,736 | $208.9K | — | |
TVTX | Dube Eric M | — | Sep 9, 2024 | Proposed Sale | $11.52 | 21,125 | $243.4K | — |
← Previous
Page 2 of 2